Product Details:
Packaging Size | 30 Tablets |
Brand | Taffic |
Manufacturer | Hetero Healthcare Ltd. |
Composition | Tenofovir Alafenamide + Bictegravir + Emtricitabine |
Treatment | HIV |
Prescription/Non prescription | Prescription |
Form | Tablet |
Shelf life | 2 Years |
Dose Strength | 275 mg |
Additional Information:
Product Details:
Packaging Size | 30 Tablets |
Brand | Vemlidy |
Manufacturer | Gilead |
Composition | Tenofovir Alafenamide |
Treatment | Hepatitis B Virus |
Prescription/Non prescription | Prescription |
Form | Tablet |
Shelf life | 2 Years |
Product Details:
Packaging Size | 30 Tablets |
Brand | Biktarvy |
Manufacturer | Gilead |
Composition | Bictegravir Emtricitabine +Tenofovir Alafenamide |
Treatment | HIV -1 |
Prescription/Non prescription | Prescription |
Form | Tablet |
Shelf life | 2 Years |
Dose Strength | 25 mg |
Product Details:
Packaging Size | 30 Tablets |
Brand | Tafnat |
Manufacturer | Natco Pharma Ltd |
Composition | Tenofovir Alafenamide |
Treatment | Hepatitis B Virus |
Prescription/Non prescription | Prescription |
Form | Tablet |
Shelf life | 2 Years |
Country of Origin | Made in India |
Product Details:
Packaging Size | 30 Tablets |
Brand | Tafero |
Manufacturer | Hetero Healthcare Limited |
Composition | Tenofovir Alafenamide 25 mg |
Treatment | Hepatitis B Virus |
Prescription/Non prescription | Prescription |
Form | Tablet |
Shelf life | 2 Years |
Product Details:
Packaging Size | 30 Tablets |
Brand | HepBest |
Manufacturer | Mylan |
Composition | Tenofovir Alafenamide |
Treatment | Hepatitis B Virus |
Form | Tablet |
Shelf life | 2 Years |
Country of Origin | Made in India |
Product Details:
Packaging Size | 30 Tablets |
Brand | Genvoya |
Manufacturer | Gilead |
Composition | Elvitegravir + Eobicistat + Emtricitabine + Tenofovir Alafenamide |
Treatment | HIV |
Prescription/Non prescription | Prescription |
Form | Tablet |
Shelf life | 2 Years |
Country of Origin | Made in India |
Dosage | Take GENVOYA Tablet only as per the dose and duration suggested by your doctor. |
Additional Information:
Product Details:
Packaging Size | 3 X 10 Tablets |
Strength | 200 Mg |
Composition | Favipiravir |
Treatment | Covid 19 |
Prescription/Non prescription | Prescription |
Form | Tablet |
Brand | Avigan |
Manufacturer | Dr Reddy's |
Shelf life | 2 Years |
Product Details:
Packaging Size | 30 Tablets per bottle |
Brand | Twinaqt |
Manufacturer | Emcure Pharmaceuticals Ltd. |
Composition | Dolutegravir 50mg and Lamivudine 300mg |
Treatment | HIV/AIDS |
Prescription/Non prescription | Prescription |
Form | Tablet |
Dolutegravir/lamivudine, sold under the brand name Dovato, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. It contains dolutegravir, an integrase inhibitor, and lamivudine, a reverse-transcriptase inhibitor. It is taken by mouth.
Dolutegravir is an integrase inhibitor, while lamivudine is a nucleoside reverse-transcriptase inhibitor.
It was approved for use in the United States in April 2019, and in the European Union in July 2019.
The most common side effects are headache, diarrhoea, nausea (feeling sick) and difficulty sleeping. The most common serious side effects are allergic reactions, including rash and severe liver problems.
Product Details:
Packaging Size | 1 X 34 Tablets |
Strength | 200 mg |
Composition | Favipiravir |
Treatment | Covid-19 mild |
Form | Tablet |
Quantity Unit | Box |
Brand | Fabiflu |
Manufacturer | Glenmark Pharmaceuticals |
Shelf life | 2 Years |
Packaging Type | Strips |
Additional Information:
Product Details:
Packaging Size | 122 Tablets |
Strength | 200 Mg |
Composition | Favipiravir |
Brand | Avigan |
Treatment | Covid 19 |
Prescription/Non prescription | Prescription |
Form | Tablet |
Manufacturer | Dr reddy's |
Shelf life | 2 Years |
Packaging Type | Bottles |
Favipiravir Tablets 200mg, sold under the brand name Avigan among others, is an antiviral medication used to treat influenza in Japan.It is also being studied to treat a number of other viral infections,including Covid-19. Like the experimental antiviral drugs T-1105 and T-1106, it is a pyrazinecarboxamide derivative.
It is being developed and manufactured by Toyama Chemical (a subsidiary of Fujifilm) and was approved for medical use in Japan in 2014.[ In 2016, Fujifilm licensed it to Zhejiang Hisun Pharmaceutical Co. of China.It became a generic drug in 2019, allowing the company to produce it in the People's Republic of China.